prostate cancer stem cell cell proliferation cell signaling dna damage response tumorigenesis (Cell Signaling Technology Inc)
94
Structured Review
Cell Signaling Technology Inc
prostate cancer stem cell cell proliferation cell signaling dna damage response tumorigenesis
Prostate Cancer Stem Cell Cell Proliferation Cell Signaling Dna Damage Response Tumorigenesis, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 521 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prostate+cancer+stem+cell+cell+proliferation+cell+signaling+dna+damage+response+tumorigenesis/ZPR1+Mouse+mAb/pm25149681-13-0-6
Average 94 stars, based on 521 article reviews
Prostate Cancer Stem Cell Cell Proliferation Cell Signaling Dna Damage Response Tumorigenesis, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 521 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prostate+cancer+stem+cell+cell+proliferation+cell+signaling+dna+damage+response+tumorigenesis/ZPR1+Mouse+mAb/pm25149681-13-0-6
Average 94 stars, based on 521 article reviews
prostate cancer stem cell cell proliferation cell signaling dna damage response tumorigenesis - by Bioz Stars,
2026-10
94/100 stars
Images
Related Articles
other:Article Title: Prostate cancer stem-like cells proliferate slowly and resist etoposide-induced cytotoxicity via enhancing DNA damage response. Article Snippet: Despite the development of chemoresistance as a major concern in prostate cancer therapy, the underlying mechanisms remain elusive.. In this report, we demonstrate that DU145-derived prostate cancer stem cells (PCSCs) progress slowly with more cells accumulating in the G1 phase in comparison to DU145 non-PCSCs.. Consistent with the important role of the AKT pathway in promoting G1 progression, DU145 PCSCs were less sensitive to growth factor-induced activation of AKT in comparison to non-PCSCs. |